The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index; 13 of the 38 sources its claims cite were checked for support.
Low-intensity blue-enriched white light (750 lux) and standard bright light (10 000 lux) are equally effective in treating SAD. A randomized controlled study
Open accessAbstract
BACKGROUND: Photoreceptor cells containing melanopsin play a role in the phase-shifting effects of short-wavelength light. In a previous study, we compared the standard light treatment (SLT) of SAD with treatment using short-wavelength blue-enriched white light (BLT). Both treatments used the same illuminance (10,000 lux) and were equally highly effective. It is still possible, however, that neither the newly-discovered photoreceptor cells, nor the biological clock play a major role in the therapeutic effects of light on SAD. Alternatively, these effects may at least be partly mediated by these receptor cells, which may have become saturated as a result of the high illuminances used in the therapy. This randomized controlled study compares the effects of low-intensity BLT to those of high-intensity SLT. METHOD: In a 22-day design, 22 patients suffering from a major depression with a seasonal pattern (SAD) were given light treatment (10,000 lux) for two weeks on workdays. Subjects were randomly assigned to either of the two conditions, with gender and age evenly distributed over the groups. Light treatment either consisted of 30 minutes SLT (5000 °K) with the EnergyLight® (Philips, Consumer Lifestyle) with a vertical illuminance of 10,000 lux at eye position or BLT (17,000 °K) with a vertical illuminance of 750 lux using a prototype of the EnergyLight® which emitted a higher proportion of short-wavelengths. All participants completed questionnaires concerning mood, activation and sleep quality on a daily basis. Mood and energy levels were also assessed on a weekly basis by means of the SIGH-SAD and other assessment tools. RESULTS: On day 22, SIGH-SAD ratings were significantly lower than on day 1 (SLT 65.2% and BLT 76.4%). On the basis of all assessments no statistically significant differences were found between the two conditions. CONCLUSION: With sample size being small, conclusions can only be preliminary. Both treatment conditions were found to be highly effective. The therapeutic effects of low-intensity blue-enriched light were comparable to those of the standard light treatment. Saturation effects may play a role, even with a light intensity of 750 lux. The therapeutic effects of blue-enriched white light in the treatment of SAD at illuminances as low as 750 lux help bring light treatment for SAD within reach of standard workplace and educational lighting systems.
Overview
CoChat Summary
TL;DR
In 22 patients with seasonal affective disorder, two weeks of low-intensity blue-enriched white light (750 lux, 17,000°K) and standard bright light (10,000 lux, 5,000°K) both substantially reduced depressive symptoms, with no statistically significant differences between conditions. The authors conclude the treatments were equally effective but preliminary because of the small sample.
Key findings
- On day 22, SIGH-SAD ratings were significantly lower than on day 1 in both groups: SLT 65.2% response and BLT 76.4% response, with effect sizes d = 2.54 and 3.53, respectively.
- No statistically significant between-condition differences were found across weekly assessments: for SIGH-SAD, main effect “time” F(3,18) = 30.2, p < 0.001; main effect “condition” F(1,20) = 0.012, ns; interaction “time*condition” F(3,60) = 0.95, ns. Similar patterns were reported for HRSD, ATYP, BDI-II, and SFQ.
- Daily self-ratings also showed significant time effects in all models but no significant time*condition interactions; for mood (AMS), time estimate = -0.946, p = .000, condition p = .283, time*condition p = .152.
- Participants rated blue-enriched light as less comfortable than standard bright light: F(1,20) = 9.61, p = 0.006.
Methods
- Randomized controlled study in winter 2008–2009 with 22 SAD patients from the University Medical Center Groningen outpatient clinic; 23 were included and 1 dropped out after concussion. SLT group: 3 men and 8 women, mean age 39.9 ± 12.7 years; BLT group: 2 men and 9 women, mean age 41.7 ± 13.1 years.
- Over a 22-day protocol, patients received 2 weeks of light treatment on 10 workdays for 30 minutes between 7:45 and 8:45 a.m.: SLT at 10,000 lux, 5000°K with EnergyLight, or BLT at 750 lux, 17,000°K with a prototype EnergyLight. Weekly assessments used SIGH-SAD, BDI-II-NL, and SFQ at days 1, 8, 15, and 22; daily assessments used AMS, GSQS, and AD-ACL.
- Baseline differences were tested with t-tests and chi-square tests; effect sizes were calculated; weekly outcomes were compared with repeated measures ANOVA for completers (n = 11 vs. 11); daily outcomes used linear mixed models with all 22 subjects, including time, condition, time*condition, and baseline score as a covariate.
Limitations
- The paper states the sample size is very small, so results can only be preliminary.
- The study had no placebo condition, so the similar responses could be interpreted as placebo effects only; the authors note this cannot be ruled out, though response rates of 65–76% were relatively high compared with placebo responses of 21–41% in prior studies and 36% in their earlier extraocular light study.
- Evident from the text: the trial was small, single-clinic, mostly female, and had no direct comparison of standard light at 750 lux versus 10,000 lux; follow-up ended at day 22, and participants were not told their condition, though SIGH-SAD interviewers were unaware of treatment assignment.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
9 Valid · 1 Not valid · 9 Not checked · 22 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The few studies testing light therapy in winter depressives using some kind of placebo condition (for example a deactivated negative-ion generator) revealed placebo effects that ranged from 21% to 41% [38-40].”
§ Low-intensity blue-enriched white light (750 lux) and standard bright light (10 000 lux) are equally effective in treating SAD. A randomized controlled study > Discussion
What the sources say
- Not checked — no full text of the sourcecites [38] Levitt AJ, Wesson VA, Joffe RT, Maunder RG, King EF: A controlled comparison of light box and head-mounted units in the treatment of seasonal depression. J Clin Psychiatry. 1996, 57: 105-110.
- Not checked — no full text of the sourcecites [39] Eastman CI, Young MA, Fogg LF, Liu L, Meaden PM: Bright light treatment of winter depression. A placebo-controlled trial. Arch Gen Psychiatry. 1998, 55: 883-889. 10.1001/archpsyc.55.10.883. source
- Supportedcites [40] Desan PH, Weinstein AJ, Michalak EE, Tam EM, Meesters Y, Ruiter MJ, Horn E, Telner J, Iskandar H, Boivin DB, Lam RW: A controlled trial of the Litebook light-emitting diode (LED) light therapy device for treatment of Seasonal Affective Disorder (SAD). BMC Psychiatry. 2007, 7: 38-10.1186/1471-244X-7-38. source
The Background and Discussion describe this as a placebo-controlled light-therapy trial for winter depression using an inactive negative-ion generator. The Results report that the control group’s final symptom score was 60.4% of its initial score in the intent-to-treat analysis—an improvement of about 40%, within the cited range. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Blue light plays a role in the working mechanism of the biological clock, but the role of the biological clock itself in the aetiology of SAD has not been fully established yet [35-37].”
§ Low-intensity blue-enriched white light (750 lux) and standard bright light (10 000 lux) are equally effective in treating SAD. A randomized controlled study > Discussion
What the sources say
- Not checked — no full text of the sourcecites [35] Meesters Y, Jansen JHC, Lambers PA, Bouhuys AL, Beersma DGM, Van den Hoofdakker RH: Morning and evening light treatment of seasonal affective disorder: response, relapse, and prediction. J Affect Disorders. 28: 165-177. 10.1016/0165-0327(93)90102-P. source
- Not checked — no full text of the sourcecites [36] Wirz-Justice A, Graw P, Kraüchi K, Gisin B, Jochum A, Arendt J, Fisch HU, Buddeberg C, Poldinger W: Light therapy in seasonal affective disorder is independent of time of day or circadian phase. Arch Gen Psych. 1993, 50: 929-937. source
- Supportedcites [37] Koorengevel KM, Beersma DGM, Den Boer JA, Van den Hoofdakker RH: Mood regulation in seasonal affective disorder patients and healthy controls studied in forced desynchrony. Psych Res. 2003, 117: 57-74. 10.1016/S0165-1781(02)00305-0. source
The Discussion reports no evidence of an abnormal circadian-pacemaker influence in the SAD patients studied, but cautions that the sample was small and calls for replication. The Introduction also describes competing circadian explanations, supporting the claim that the biological clock’s role in SAD remains unsettled. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Studies by Smith et al. [32,33], have demonstrated that, in a similar way, frequently used bright-light therapy photon densities (4.2 vs. 4.9 10E15 photons/cm2/s), blue-enriched white light (17 000 °K) does not outperform standard white light (4100 °K) in phase-advancing or phase-delaying effects.”
§ Low-intensity blue-enriched white light (750 lux) and standard bright light (10 000 lux) are equally effective in treating SAD. A randomized controlled study > Discussion
What the sources say
- Partly supportedcites [32] Smith MR, Eastman CI: Phase delaying the human circadian clock with blue-enriched polychromatic light. Chronobiology International. 2009, 26: 709-725. 10.1080/07420520902927742. sourceExperimental — accuracy not yet measured
The Abstract reports no significant difference between phase delays under 17,000 K blue-enriched and 4,100 K white light, and says a previous study found no difference in phase advances. However, the Methods (Bright-Light Treatment; page unavailable) state that both conditions in this study delivered 4.2 × 10¹⁵ photons/cm²/s; this paper does not establish the cited 4.9 × 10¹⁵ figure. (LLM, conf=0.86)
- Partly supportedcites [33] Smith MR, Revell VL, Eastman CI: Phase advancing the human circadian clock with blue-enriched polychromatic light. Sleep Medicine. 2009, 10: 287-294. 10.1016/j.sleep.2008.05.005. sourceExperimental — accuracy not yet measured
The Methods (Light Treatment; page unavailable) report the stated color temperatures and photon densities, and the Discussion says blue-enriched light did not produce larger phase advances than standard white light. This paper used a phase-advancing protocol, however, and does not establish the claimed comparison for phase delays. Its Discussion mentions a different phase-delay study but not a delay comparison of these two lights. (LLM, conf=0.88)
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“It has been shown that sleep quality and alertness improved when workers spent their day in an office with blue-enriched white light with an intensity of 310.35 lux in the daytime instead of in the standard white (4000 °K) office lighting conditions with a mean intensity of 421.07 lux [29].”
§ Low-intensity blue-enriched white light (750 lux) and standard bright light (10 000 lux) are equally effective in treating SAD. A randomized controlled study > Discussion
What the sources say
- Supportedcites [29] Viola AU, James LM, Schlangen LJM, Dijk DJ: Blue-enriched white light in the workplace improves self-reported alertness, performance and sleep quality. Scand J Work Environ Health. 2008, 34: 297-306. source
The Abstract reports improved subjective alertness and sleep quality under blue-enriched white light compared with 4000 K white light. The Lighting section gives mean work-surface illuminances of 310.35 lx and 421.07 lx, respectively. The paper reports these as self-reported outcomes. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As can be seen from Table 2, in all models baseline severity was related to outcome, with higher baseline scores predicting higher overall follow-up scores.”
§ Low-intensity blue-enriched white light (750 lux) and standard bright light (10 000 lux) are equally effective in treating SAD. A randomized controlled study > Results > Impact of baseline severity on outcome
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
10 more claims
Create a free account to see all 41 claims and to verify the 3 references still open.
- It may state two separate claims as one. 12
- Probably not a substantial claim. 17
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Fourteen articles[25–36,38,39] reported the effects of various visible light interventions on SIGH-SAD of patients with SAD.”
From Effectiveness of visible light for seasonal affective disorder: A systematic review and network meta-analysis (2025) · cites this paper as [31]
The cited source says what the claim attributes to it.
In the citing paper
“Thirteen articles[23,28–38,40] reported the effects of different visible light interventions on HDRS of patients with SAD”
From Effectiveness of visible light for seasonal affective disorder: A systematic review and network meta-analysis (2025) · cites this paper as [31]
Statistics recomputed
Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.
- ConsistentF(3, 18) = 30.2reported p < .001 · recomputed p < .001
“F(3,18) = 30.2, p < .001”
- ConsistentF(1, 20) = 0.012reported n.s. · recomputed p = .914
“F(1,20) = 0.012, ns”
- ConsistentF(3, 60) = 0.95reported n.s. · recomputed p = .422
“F(3,60) = 0.95, ns”
- ConsistentF(3, 18) = 28.2reported p < .001 · recomputed p < .001
“F(3,18) = 28.2, p < .001”
- ConsistentF(1, 20) = 0reported n.s. · recomputed p = 1.000
“F(1,20) = 0.00, ns”
11 more recomputed tests
Create a free account to see every test the Stats check recomputed.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Low-intensity blue-enriched white light (750 lux) and standard bright light (10 000 lux) are equally effective in treating SAD. A randomized controlled study > Abstract > Method
“22 patients suffering from a major depression with a seasonal pattern (SAD) were given light treatment (10 000 lux) for two weeks on workdays.”
§ Low-intensity blue-enriched white light (750 lux) and standard bright light (10 000 lux) are equally effective in treating SAD. A randomized controlled study > Abstract > Method
“Light treatment either consisted of 30 minutes SLT (5000°K) with the EnergyLight® (Philips, Consumer Lifestyle) with a vertical illuminance of 10 000 lux at eye position or BLT (17 000°K) with a vertical illuminance of 750 lux”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Low-intensity blue-enriched white light (750 lux) and standard bright light (10 000 lux) are equally effective in treating SAD. A randomized controlled study > Discussion
“The response rates in the current study between 65% and 76% for remission are relatively high compared to the placebo responses from the placebo-controlled studies”
§ Low-intensity blue-enriched white light (750 lux) and standard bright light (10 000 lux) are equally effective in treating SAD. A randomized controlled study > Results > Weekly assessments
“| SIGH-SAD | SLT | 11 | 25.6 (6.3) | 18.1 (8.0) | 10.9 (4.4) | 8.9 (6.8) | 2.54 | 65.2 | 8 | | | BLT | 11 | 25.4 (6.9) | 19 (6.0) | 14 (10.1) | 6 (4.0) | 3.53 | 76.4 | 11 |”
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Diagnostic and Statistical Manual of Mental Disorders
(2012) · SpringerReference · doi:10.1007/springerreference_121117 · Cited by 20,570
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
Journal of Clinical Psychiatry
(2018) · Journal of Clinical Psychiatry · doi:10.5505/kpd · Cited by 13,651
(1998) · PubMed · Cited by 10,216
Beck, A. T., Steer, R. A., & Brown, G. (2011) · PsycTESTS Dataset · doi:10.1037/t00742-000 · Cited by 7,535
The mini international neuropsychiatric interview
Lecrubier, Y., Sheehan, D., Hergueta, T., & Weiller, E. (1998) · European Psychiatry · doi:10.1016/s0924-9338(99)80239-9 · Cited by 5,872
Phototransduction by retinal ganglion cells that set the circadian clock
Berson, D. M., Dunn, F. A., & Takao, M. (2002) · Science · doi:10.1126/science.1067262 · Cited by 3,629 · cited 2×
“This new photoreceptor plays a major role in regulating the biological clock [5,7] and is also involved in pupillary constriction [8].”
BackgroundMendelson, G. (1995) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048679509064964 · Cited by 2,858
Hattar, S., Liao, H.-W., Takao, M., Berson, D. M., & Yau, K.-W. (2002) · Science · doi:10.1126/science.1069609 · Cited by 2,734 · cited 1×
“A recent scientific development has been the discovery of a novel photoreceptor, melanopsin, within the basal ganglia of the retina [ 4-6 ].”
Background
Research works printed but not linked: 6
- CIE Central Bureau,Vienna, Austria: Photobiological Safety of Lamps and Lamp Systems, CIE Standard CIE S 009/E. 2002, UDC: 612.014.481
- Williams JBW, Link MJ, Rosenthal NE, Amira L, Terman M: Structured Interview Guide for the Hamilton Depression Rating Scale- Seasonal affective disorder version. 1994, New York: New York State Psychiatric Institute
- Alberts M, Smets EMA, Vercoulen JHMM, Garssen B, Bleijenberg G: Verkorte Vermoeidheids Vragenlijst: een praktisch hulpmiddel bij het scoren van vermoeidheid. Nederlands Tijdschrift voor de Geneeskunde. 1997, 141: 1526-1530.
- Von Zerssen D: Die Befindlichkeitsskala. Manual. 1976, Weinheim: Beltz Test Verlag
- Mulder-Hajonides v.d. Meulen WREH, Wijnberg JR, Hollander JJ, De Diana IPF, Van den Hoofdakker RH: Measurement of subjective sleep quality. Fifth European Sleep Congress of the European Sleep Research Society, September, 2-5. 1980, Amsterdam, The Netherlands, 98-[abstract]
- Cohen J: Statistical power analysis for the behavioural sciences. 1988, Hillsdale, New Jersey: Lawrence Erlbaum
Cited by
Malhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
“There is some evidence that light treatment can be effective at lower intensity if the source emits blue-enriched light (Meesters et al., 2011).”
BackgroundFigueiro, M., Plitnick, B., Lok, A., Jones, G., Higgins, P., Hornick, T., & Rea, M. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s68557 · Cited by 211
Circadian rhythms and depression: Human psychopathology and animal models
Kronfeld-Schor, N., & Einat, H. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.020 · Cited by 166
Human phase response curve to a single 6.5 h pulse of short‐wavelength light
Rüger, M., St Hilaire, M. A., Brainard, G. C., Khalsa, S. S., Kronauer, R. E., Czeisler, C. A., & Lockley, S. W. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2012.239046 · Cited by 161
“The Journal of Physiology C© 2012 The Physiological Society white light typically employed (2500–10,000 lux), at lower irradiances and with relatively short exposures (45 min) (Glickman et al. 2006; Anderson et al. 2009; Strong et al. 2009; Meesters et al. 2011).”
BackgroundBiological rhythms and chronotherapeutics in depression
Geoffroy, P. A., & Palagini, L. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110158 · Cited by 127
Metadata
- Authors
- Meesters, Y., Dekker, V., Schlangen, L. J., Bos, E. H., & Ruiter, M. J.
- Affiliations
- University Medical Center Groningen (NL)
- Signify (Netherlands) (NL)
- University of Groningen (NL)
- Corresponding author
- Meesters, Ybe
- Venue
- BMC Psychiatry
- Published
- 2011-01-28
- Volume
- 11
- Issue
- 1
- Pages
- 17-17
- ISSN
- 1471-244X (ISSN-L)
- PMC
- PMC3042929
- OpenAlex
- W1980697377
- Cited by
- 98
- References
- 43
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 4 · 2023: 4 · 2022: 3 · 2021: 6 · 2020: 7 · 2019: 11 · 2018: 9 · 2017: 7 · 2016: 7 · 2015: 6 · 2014: 7 · 2013: 6 · 2012: 9
- FWCI
- 3.84
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0 (tdm)
- Locations
- BMC Psychiatry (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- TU/e Research Portal (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Light effects on plants
- Keywords
- seasonal affective disorder, phototherapy, low-intensity light, illuminance, photoreceptors, melanopsin, circadian rhythm, mood, sleep quality, energy levels, receptor saturation, short-wavelength light, treatment efficacy comparison
- MeSH terms
- Adult, Ambulatory Care, Circadian Rhythm, Color, Female, Humans, Light, Male, Phototherapy, Sleep, Seasonal Affective Disorder, Treatment Outcome, Photons, Luminescence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Low-intensity blue-enriched white light (750 lux) and standard bright light (10 000 lux) are equally effective in treating SAD. A randomized controlled study. https://app.cochat.ai/papers/10.1186/1471-244x-11-17
- The paper
- Meesters, Y., Dekker, V., Schlangen, L. J., Bos, E. H., & Ruiter, M. J. (2011). Low-intensity blue-enriched white light (750 lux) and standard bright light (10 000 lux) are equally effective in treating SAD. A randomized controlled study. BMC Psychiatry. https://doi.org/10.1186/1471-244x-11-17
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.